# Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/

> **NIH NIH UM1** · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2020 · $181,942,638

## Abstract

To more safely and efficiently treat COVID-19 participants, we request support to place COVID-19 Isolation PODS at 14 of the ACTG CRSs. The storage company, PODS, has developed stand-alone and CDC compliant units. 

Installation of a COVID-19 POD at CRS locations will primarily facilitate A5401 but also protocol A5395. These units additionally allow separation between these activities and our HIV patients for both COVID treatment and prevention studies. 

A5401 will study up to 10 different agents across phase 2 and phase 3 trials. This dedicated space will allow for efficient treatment of a high volume of study participants without comprising infection control measures of the general clinic population.

## Key facts

- **NIH application ID:** 10182391
- **Project number:** 3UM1AI068636-14S2
- **Recipient organization:** UNIVERSITY OF CALIFORNIA LOS ANGELES
- **Principal Investigator:** Judith S. Currier
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $181,942,638
- **Award type:** 3
- **Project period:** 2020-06-24 → 2020-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10182391

## Citation

> US National Institutes of Health, RePORTER application 10182391, Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ (3UM1AI068636-14S2). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10182391. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*